Keyphrases
Otitis Media
100%
Pneumococcal Conjugate Vaccine
100%
Streptococcus Pneumoniae
100%
Pneumococcal Serotypes
36%
PCV7
27%
Progression Rate
27%
Jewish children
27%
Bedouin children
27%
Pneumococcus
18%
Vaccine Serotypes
18%
Serotype-specific
18%
Active Surveillance
18%
Southern Israel
9%
Middle Ear Fluid
9%
Nasopharyngeal Carriage
9%
Vaccine Impact
9%
Upper Respiratory Tract
9%
Population-based
9%
Credible Interval
9%
Low Dose Rate
9%
Estimated Rates
9%
Vaccine Rollout
9%
3-year-olds
9%
Bayesian Random Effect Models
9%
Background Removal
9%
Immunology and Microbiology
Otitis Media
100%
Serotype
100%
Pneumococcal Vaccine
100%
Streptococcus Pneumoniae
100%
Vaccine Efficacy
63%
Liquid
9%
Infectious Agent
9%
Middle Ear
9%
Prevalence
9%
Upper Respiratory Tract
9%
Medicine and Dentistry
Serotype
100%
Pneumococcus Vaccine
100%
Otitis Media
100%
Streptococcus Pneumoniae
100%
Disease
9%
Prospective Study
9%
Middle Ear
9%
Pathogen
9%
Random Effects Model
9%
Prevalence
9%
Upper Respiratory Tract
9%
Pharmacology, Toxicology and Pharmaceutical Science
Streptococcus Pneumoniae
100%
Pneumococcus Vaccine
100%
Otitis Media
100%
Disease
9%
Infectious Agent
9%
Prevalence
9%
Random Effects Model
9%
Respiratory Tract
9%
Prospective Study
9%